Serum Institute Of India , world’s largest vaccine maker developed a vaccine AstraZeneca with the help of Oxford University and the British Pharmaceutical company AstraZeneca. The vaccine is now in phasing III clinical trials. After the trial’s end Serum Institute will start the production unit of the vaccine. In India, it’s a big challenge to distribute the vaccine for 130 crore people.
Serum Institute’s CEO Adar Poonawalla asked the Govt and also the Ministry of health and Family Welfare that, how the government will plan this kind of vaccine distribution?. This is the main challenge to Govt have to tackle it. The Govt needs almost 80,000 crore for the vaccine in the next one year. Poonawalla also said that,”I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution.”
There are 5 companies who are developing the vaccine, Bharat Biotech, Zydus Cadila , Serum Institute , Biological E and Gennova Biopharmaceuticals. Zydus Cadila already clear the pre-clinical phase. Bharat Botech is now conducting a phase II human trials. Zydus Cadila have already sent a phase III human trial notice to the DGCI and is waiting for the approval.
The government said that, they have the sitemap of the distribution process of the vaccine. They will distribute the vaccine through UIP (Universal Immunization Program) with phased manner and that will cover all the districts.